2016
DOI: 10.3171/2016.7.focus16231
|View full text |Cite
|
Sign up to set email alerts
|

Laser interstitial thermal therapy for subependymal giant cell astrocytoma: technical case report

Abstract: Subependymal giant cell astrocytoma (SEGA) is a rare tumor occurring almost exclusively in patients with tuberous sclerosis complex. Although open resection remains the standard therapy, complication rates remain high. To minimize morbidity, less invasive approaches, such as endoscope-assisted resection, radiosurgery, and chemotherapy with mTOR pathway inhibitors, are also used to treat these lesions. Laser interstitial thermal therapy (LITT) is a relatively new modality that is increasingly used to tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 16 publications
0
23
0
Order By: Relevance
“…9 Dadey et al reported 2 pediatric cases of sub-ependymal giant cell astrocytoma (SEGA) treated with LITT, with both patients having significant improvement in symptoms and interval decrease in lesion size at the 9-month follow-up. 5 Tovar-Spinoza and Choi reported a series of 11 patients with 12 tumors including pilocytic astrocytoma, ependymoma, recurrent medulloblastoma, choroid plexus xanthogranuloma, SEGA, and ganglioglioma, in which 9 of the patients underwent LITT as initial therapy and 2 patients received it in an adjuvant fashion after other measures had failed. Postablation complications occurred in 2 patients, both of whom improved with rehabilitation with reduction of tumor volume in all instances.…”
mentioning
confidence: 99%
“…9 Dadey et al reported 2 pediatric cases of sub-ependymal giant cell astrocytoma (SEGA) treated with LITT, with both patients having significant improvement in symptoms and interval decrease in lesion size at the 9-month follow-up. 5 Tovar-Spinoza and Choi reported a series of 11 patients with 12 tumors including pilocytic astrocytoma, ependymoma, recurrent medulloblastoma, choroid plexus xanthogranuloma, SEGA, and ganglioglioma, in which 9 of the patients underwent LITT as initial therapy and 2 patients received it in an adjuvant fashion after other measures had failed. Postablation complications occurred in 2 patients, both of whom improved with rehabilitation with reduction of tumor volume in all instances.…”
mentioning
confidence: 99%
“…LITT has also been advocated for newly diagnosed and recurrent pediatric brain tumors [136]. LITT-treated pathologies include: pilocytic astrocytomas [136][137][138], ependymomas [77,103,139], medulloblastomas [136,138], choroid plexus xanthogranulomas [136,138], subependymal giant cell astrocytomas [136,138,[140][141][142], gangliogliomas [136,138,143], neuroectodermal tumors [77,103,144], gliosis [143], RN [143] and hypothalamic hamartomas [140]. Reported indications include deep-seated and recurrent, tumors [136,145].…”
Section: Pediatric Tumorsmentioning
confidence: 99%
“…Ideal candidates have evidence of a unilateral mesial temporal focus without neocortical temporal lobe involvement, 69,[76][77][78] hypothalamic hamartomas, 79 complex and deep focal cortical dysplasias, 80 tuberous sclerosis, 81 and subependymal giant cell astrocytomas. 82,83 LITT has also been used for disconnection procedures such as corpus callosotomy 84 and in combination with open temporal lobectomy and topectomy. 72,80,85 LITT can be repeated to augment the initial ablation if clinical results are suboptimal and/or if imaging reveals residual seizure focus.…”
Section: Historymentioning
confidence: 99%